ABBOTT PARK, Ill., April 11 /PRNewswire-FirstCall/ -- Abbott announced today that the European Commission has cleared its proposed acquisition of Guidant’s vascular business. The proposed transaction is also currently under review by the U.S. Federal Trade Commission.
About Abbott
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 60,000 people and markets its products in more than 130 countries.
Abbott’s news releases and other information are available on the company’s Web site at www.abbott.com.
Abbott Laboratories
CONTACT: Media, Melissa Brotz, +1-847-935-3456, or Jonathon Hamilton,+1-847-935-8646, or Financial Community, John Thomas, +1-847-938-2655, orTina Ventura, +1-847-935-9390, all of Abbott
Web site: http://www.abbott.com/
Company News On-Call: http://www.prnewswire.com/comp/110328.html /
